Efficacy & Safety of TD-1473 in Ulcerative Colitis

Stopped Stopped early due to company decision. Company decision based on interim analysis results in TD-1473-0157.

Conditions

• Ulcerative Colitis (UC)

Interventions

• DRUG: TD-1473 Dose A
• DRUG: TD-1473 Dose B
• DRUG: TD-1473 Dose C
• DRUG: Placebo

Sponsor

Theravance Biopharma